PepsiCo Q2 Earnings: Pricing Power and GLP-1 Headwinds in Focus

PepsiCo is set to release its second-quarter results at 6:00 AM ET on July 9, before U.S. markets open. The report arrives at a pivotal moment for the snack-and-beverage giant, as investors look for evidence that the company can sustain the pricing strategies that have defined its post-pandemic recovery.

A central question heading into the print is how GLP-1 weight-loss drugs are affecting consumer demand for PepsiCo's core products. These medications have been linked to reduced appetite for sugary drinks and snack foods — two categories that sit at the heart of PepsiCo's portfolio — and Wall Street wants to know whether any volume softness is showing up in the numbers.

Beyond GLP-1 pressure, the earnings call will likely draw scrutiny on how management is navigating a broader environment of cost-conscious consumers. Whether PepsiCo can hold pricing while protecting unit volumes will be the defining tension investors are watching as results hit before the opening bell.